Cargando…

Markers of Cancer Cell Invasion: Are They Good Enough?

Invasion, or directed migration of tumor cells into adjacent tissues, is one of the hallmarks of cancer and the first step towards metastasis. Penetrating to adjacent tissues, tumor cells form the so-called invasive front/edge. The cellular plasticity afforded by different kinds of phenotypic transi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gerashchenko, Tatiana S., Novikov, Nikita M., Krakhmal, Nadezhda V., Zolotaryova, Sofia Y., Zavyalova, Marina V., Cherdyntseva, Nadezhda V., Denisov, Evgeny V., Perelmuter, Vladimir M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6723901/ https://www.ncbi.nlm.nih.gov/pubmed/31344926 http://dx.doi.org/10.3390/jcm8081092

Ejemplares similares

The Activity of KIF14, Mieap, and EZR in a New Type of the Invasive Component, Torpedo-Like Structures, Predetermines the Metastatic Potential of Breast Cancer
por: Gerashchenko, Tatiana S., et al.
Publicado: (2020)

Phenotypic Drift as a Cause for Intratumoral Morphological Heterogeneity of Invasive Ductal Breast Carcinoma Not Otherwise Specified
por: Zavyalova, Marina V., et al.
Publicado: (2013)

Intratumoral morphological heterogeneity of breast cancer: neoadjuvant chemotherapy efficiency and multidrug resistance gene expression
por: Denisov, Evgeny V., et al.
Publicado: (2014)

Cancer Invasion: Patterns and Mechanisms
por: Krakhmal, N. V., et al.
Publicado: (2015)

Intratumoral Morphological Heterogeneity of Breast Cancer As an Indicator of the Metastatic Potential and Tumor Chemosensitivity
por: Gerashchenko, T.S., et al.
Publicado: (2017)

Mechanisms behind prometastatic changes induced by neoadjuvant chemotherapy in the breast cancer microenvironment
por: Perelmuter, Vladimir M, et al.
Publicado: (2019)

Clinically relevant morphological structures in breast cancer represent transcriptionally distinct tumor cell populations with varied degrees of epithelial-mesenchymal transition and CD44(+)CD24(-) stemness
por: Denisov, Evgeny V., et al.
Publicado: (2017)

Heterogeneous Manifestations of Epithelial–Mesenchymal Plasticity of Circulating Tumor Cells in Breast Cancer Patients
por: Tashireva, Liubov A., et al.
Publicado: (2021)

Mutational drivers of cancer cell migration and invasion
por: Novikov, Nikita M., et al.
Publicado: (2020)

The Novel Association of Early Apoptotic Circulating Tumor Cells with Treatment Outcomes in Breast Cancer Patients
por: Grigoryeva, Evgeniya S., et al.
Publicado: (2022)

Single Tumor Cells With Epithelial-Like Morphology Are Associated With Breast Cancer Metastasis
por: Tashireva, Liubov A., et al.
Publicado: (2020)

Heterogeneity of Stemlike Circulating Tumor Cells in Invasive Breast Cancer
por: Savelieva, Olga E., et al.
Publicado: (2020)

Premalignant Changes in the Bronchial Epithelium Are Prognostic Factors of Distant Metastasis in Non-Small Cell Lung Cancer Patients
por: Pankova, Olga V., et al.
Publicado: (2021)

Neoadjuvant chemotherapy combined with intraoperative radiotherapy is effective to prevent recurrence in high-risk non-small cell lung cancer (NSCLC) patients
por: Pankova, Olga V., et al.
Publicado: (2020)

Cortical branched actin determines cell cycle progression
por: Molinie, Nicolas, et al.
Publicado: (2019)

Spatial Profile of Tumor Microenvironment in PD-L1-Negative and PD-L1-Positive Triple-Negative Breast Cancer
por: Tashireva, Liubov A., et al.
Publicado: (2023)

Because good enough is never good enough
por: John, M
Publicado: (2012)

Molecular subtype conversion in CTCs as indicator of treatment adequacy associated with metastasis-free survival in breast cancer
por: Grigoryeva, E. S., et al.
Publicado: (2022)

Belatacept: Good, but not good enough?
por: Parameswaran, Sreejith, et al.
Publicado: (2012)

Alpha-Synuclein as a Biomarker of Parkinson’s Disease: Good, but Not Good Enough
por: Ganguly, Upasana, et al.
Publicado: (2021)

LIMCH1 as a New Potential Metastasis Predictor in Breast Cancer
por: Alifanov, Vladimir Valerievich, et al.
Publicado: (2022)

NOT "Good Enough for the War."
Publicado: (1916)

Good-Enough Synthesis
por: Almagor, Shaull, et al.
Publicado: (2020)

Pandemics: good hygiene is not enough
por: Sandman, Peter M.
Publicado: (2009)

Guesstimates are not good enough for determining what is happening in routine care
por: Heong, V, et al.
Publicado: (2010)

Dataset on the interview-based survey of Moscow bicycle infrastructure
por: Zavyalova, Nadezhda, et al.
Publicado: (2019)

Quality of care: how good is good enough?
por: Chassin, Mark R
Publicado: (2012)

RESEARCH IN INDIA: NOT GOOD ENOUGH?
por: Patel, Vikram
Publicado: (2001)

Real-time linkage: when is near enough good enough?
por: Irvine, Katrina, et al.
Publicado: (2017)

Deletions of multidrug resistance gene loci in breast cancer leads to the down-regulation of its expression and predict tumor response to neoadjuvant chemotherapy
por: Litviakov, Nikolai V., et al.
Publicado: (2016)

Genomic and Transcriptomic Research in the Discovery and Application of Colorectal Cancer Circulating Markers
por: Ponomaryova, Anastasia A., et al.
Publicado: (2023)

The Association of Integrins β3, β4, and αVβ5 on Exosomes, CTCs and Tumor Cells with Localization of Distant Metastasis in Breast Cancer Patients
por: Grigoryeva, Evgeniya S., et al.
Publicado: (2023)

Good enough practices in scientific computing
por: Wilson, Greg, et al.
Publicado: (2017)

Are Good Intentions Good Enough?: Informed Consent Without Trained Interpreters
por: Hunt, Linda M., et al.
Publicado: (2007)

Effect of vitamin D3 supplementation on cellular immunity and inflammatory markers in COVID-19 patients admitted to the ICU
por: Bychinin, Mikhail V., et al.
Publicado: (2022)

Tumor-associated macrophages in human breast cancer produce new monocyte attracting and pro-angiogenic factor YKL-39 indicative for increased metastasis after neoadjuvant chemotherapy
por: Liu, Tengfei, et al.
Publicado: (2018)

Interaction of tumor-associated macrophages and cancer chemotherapy
por: Larionova, Irina, et al.
Publicado: (2019)

Good Enough? Terlipressin, Hepatorenal Syndrome, and the Usage of RRT
por: Belcher, Justin M.
Publicado: (2023)

Plasma miR-19b and miR-183 as Potential Biomarkers of Lung Cancer
por: Zaporozhchenko, Ivan A., et al.
Publicado: (2016)

Profiling of 179 miRNA Expression in Blood Plasma of Lung Cancer Patients and Cancer-Free Individuals
por: Zaporozhchenko, Ivan A., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_qvbq5nh8f626855ju0refipdcn